Application of penehyliclidine hydrochloride in preparing medicine

A technology of penehyclidine hydrochloride and its use, applied in the directions of anti-infective drugs, drug combinations, etc., can solve the problems such as medical clinical effects that have been found and confirmed before, and can reduce the symptoms of rigidity and tremor, inhibit the Salivation and excessive sweating, the effect of obvious curative effect

Inactive Publication Date: 2006-03-01
CHENGDU LIST PHARMA
View PDF0 Cites 19 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

Prior to this, penehyclidine hydrochloride has been found and confirmed to have the efficacy and clinical efficacy of rescuing organophosphate poisoning, but no other medical clinical effects have been found

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0034] The application of the present invention in the preparation of medicaments for treating gastrointestinal diseases includes: A, the therapeutic application of peptic ulcer; Therapeutic application of hypermotility of the small intestine, dysentery and rectal irritation; C, inhibition of saliva secretion, salivation of Parkinson's disease, and saliva dysphagia caused by esophageal mechanical obstruction.

[0035] Medication can be taken orally, intramuscularly or intravenously, and the preferred dosage range is 0.01-10mg / time.

Embodiment 2

[0037] The application of the present invention in ophthalmic diseases in clinical medicine includes: A, pupil dilation, fundus examination, and iritis, keratitis, and anti-adhesion treatment applications; B, application for regulating paralysis in optometry.

[0038] The dosage form can be selected as eye drops or eye paint, and the preferred concentration is 0.03-3%.

Embodiment 3

[0040] The clinical application of the present invention in respiratory diseases includes: A, the application of relieving cold and acute and chronic rhinitis; B, the application of relieving asthma.

[0041] The dosage forms can be nasal drops or sprays, and the preferred concentration is 0.025-2.8.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The present invention relates to the application of penehyclidine hydrochloride in preparing medicine, and is especially the application of penehyclidine hydrochloride in preparing medicine for resisting infectious shock. Animal experiment and clinical observation prove the curative effect of penehyclidine hydrochloride in resisting infectious shock and improving micro circulation. The present invention expands the medicinal use of penehyclidine hydrochloride.

Description

Technical field: [0001] The invention relates to the application of penehyclidine hydrochloride, in particular to the application of penehyclidine hydrochloride in clinical medicine for gastrointestinal diseases, eye diseases, respiratory diseases, central nervous system diseases, anesthesia, urogenital tract renal colic and bladder irritation Syndrome, anti-septic shock, anti-biliary colic, etc. Background technique: [0002] Penehyclidine hydrochloride, English name: Penehyclidine Hydrochloride, its chemical name is 3-(2-cyclopentyl-2-hydroxy-2-phenylethoxy)quinuclidine hydrochloride, molecular formula: C 20 h 29 NO 2 • CH1, molecular weight: 351.92. Prior to this, penehyclidine hydrochloride has been found and confirmed to have the efficacy and clinical efficacy of rescuing organophosphate poisoning, but no other medical clinical effects have been found. Invention content: [0003] The purpose of the present invention is to propose new indications of penehyclidine h...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Patent Type & Authority Applications(China)
IPC IPC(8): A61K31/439A61P31/00A61P43/00
Inventor 倪友洪蒲春霞雍萍曹勇王卫国
Owner CHENGDU LIST PHARMA
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap